Many older people's glasses of wrong power

January 14, 2020

Overall, Swedish 70-year-olds' eyesight is good, but many could see even better. Six in ten can improve their vision by getting eyeglasses or changing the power of the glasses they already have, according to a new study from the University of Gothenburg.

"We're really healthy and have good eyesight in Sweden, and being 70 doesn't have to mean your vision is poor. It's easy to get it checked by an optician, who can offer the right glasses or refer you to an ophthalmologist if necessary," says Lena Havstam Johansson, PhD student at Sahlgrenska Academy, University of Gothenburg, and ophthalmic nurse at Sahlgrenska University Hospital.

In the study, the great majority of 70-year-olds were content with their eyesight, but many overestimated how well they can actually see. More than half (61.5 percent) proved able to see considerably better by getting glasses or changing the power of the ones they already had.

"Visual impairment can creep up on you, making it difficult to notice that your eyes are getting worse. So it's a good idea to visit an optician regularly when you get older, even if you don't feel your sight is deteriorating," Havstam Johansson says.

The study shows that how people perceive their own eyesight corresponds poorly with reality. Of those whose vision had deteriorated, the majority nonetheless regarded their eyesight as good.

"Above all, it was reduced contrast sensitivity that made people think their sight was poor. Impaired visual acuity or visual field defects had less of an impact on how they perceived their own eyesight," says Madeleine Zetterberg, Professor of Ophthalmology at the University of Gothenburg's Sahlgrenska Academy and coauthor of the study.

The study covers 1,200 Gothenburg residents who had all answered a special "self?reported ocular morbidity questionnaire" on how they perceived their eyesight and thought their everyday lives were being affected by vision problems.

In cooperation with a colleague, Lena Havstam Johansson also investigated the eyesight of nearly half (560) of these 70-year-olds, in several ways. They examined the study participants' central vision (the part we use when we watch TV or look at a painting, for example), their peripheral vision (the part that enables us to pick up what is going on outside our field of focus), and their ability to perceive contrasts (contrast sensitivity). In addition, every study participant's lens and retina were photographed to detect eye disease, if any.

Having glasses of incorrect power was equally common in men and women in the study but, in general, the men had slightly better eyesight than the women. This may be explained partly by the higher prevalence of cataract among women generally. This was confirmed in the present study: Just over 27 percent of the women had cataract, but only just over 19 percent of the men. Many respondents who proved to have cataract were already aware that they had this eye disease, while others learned of it when they had their eyes tested. The most common eye disease among the study participants examined was cataract (23.4%), followed by age-related macular degeneration (AMD, 4.7%) and glaucoma (4.3%), while 1.4% had diabetic retinopathy (retinal changes due to diabetes).

These and other findings of the present study were recently accepted for publication in the scientific journal Acta Ophthalmologica. The study forms part of the H70 population-based study of aging and its diseases that has been underway at the University of Gothenburg since the early 1970s. This H70 study provides a picture of the trends of life and health among ordinary 70-year-olds, and also scope for comparing what getting older has been like for different generations.
-end-


University of Gothenburg

Related Eye Disease Articles from Brightsurf:

The natural artistry of disease: a wintry landscape in the eye
Researchers from Tokyo Medical and Dental University (TMDU) report a case of frosted branch angiitis in a woman presenting years after being treated for leukemia-lymphoma with allogeneic human stem cell transplant.

Potential new treatment for severe dry eye disease, RCSI Research
Scientists have discovered a potential new treatment for a disease that causes severe dry eyes and dry mouth.

Researchers pinpoint potential new therapeutic target for eye disease
Multi-disciplinary work led by researchers from Trinity College Dublin has pinpointed a potential new therapeutic target for treating retinal degeneration.

New discovery has important implications for treating common eye disease
Scientists from Trinity College Dublin have made an important discovery with implications for those living with a common, debilitating eye disease (age-related macular degeneration, AMD) that can cause blindness.

New treatment discovered for rare eye disease may prevent blindness
Patients with thyroid eye disease who used the minimally invasive insulin-like growth factor I blocking antibody, teprotumumab, experienced improvement in their symptoms, appearance and quality of life, according to a study recently published in the New England Journal of Medicine.

Helper protein worsens diabetic eye disease
In a recent study using mice, lab-grown human retinal cells and patient samples, Johns Hopkins Medicine scientists say they found evidence of a new pathway that may contribute to degeneration of the light sensitive tissue at the back of the eye.

Using AI to screen for diabetic eye disease feasible in the real world
New research shows that an automated, artificial intelligence (AI) screening system accurately detects diabetic retinopathy 95.5 percent of the time.

Sleep apnea linked to blinding eye disease in people with diabetes
New research from Taiwan shows that severe sleep apnea is a risk factor for developing diabetic macular edema, a complication of diabetes that can cause vision loss or blindness.

Antibody-based eye drops show promise for treating dry eye disease
Researchers have identified the presence of a specific type of antibody, called anti-citrullinated protein autoantibodies, or ACPAs, in human tear fluid.

Genetic discovery linked to rare eye disease, MacTel
Paul S. Bernstein, M.D., Ph.D., spent more than a decade working with families at the John A.

Read More: Eye Disease News and Eye Disease Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.